These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28342669)

  • 41. Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.
    Kastenmüller K; Espinosa DA; Trager L; Stoyanov C; Salazar AM; Pokalwar S; Singh S; Dutta S; Ockenhouse CF; Zavala F; Seder RA
    Infect Immun; 2013 Mar; 81(3):789-800. PubMed ID: 23275094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
    Jaijyan DK; Singh H; Singh AP
    J Biol Chem; 2015 Aug; 290(32):19496-511. PubMed ID: 25960542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.
    Liu F; Li L; Zheng W; He Y; Wang Y; Zhu X; Tsuboi T; Cui L; Wang M; Cao Y
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimod.
    Othoro C; Johnston D; Lee R; Soverow J; Bystryn JC; Nardin E
    Infect Immun; 2009 Feb; 77(2):739-48. PubMed ID: 19047411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J; Matuschewski K
    Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.
    Halbroth BR; Sebastian S; Salman AM; Ulaszewska M; Gola A; Longley RJ; Janse CJ; Khan SM; Hill AVS; Spencer AJ
    Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31740525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    Speake C; Pichugin A; Sahu T; Malkov V; Morrison R; Pei Y; Juompan L; Milman N; Zarling S; Anderson C; Wong-Madden S; Wendler J; Ishizuka A; MacMillen ZW; Garcia V; Kappe SH; Krzych U; Duffy PE
    PLoS One; 2016; 11(7):e0159449. PubMed ID: 27434123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity.
    Mitchell RA; Altszuler R; Frevert U; Nardin EH
    Sci Rep; 2016 Sep; 6():32575. PubMed ID: 27624667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
    Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model.
    Mizutani M; Fukumoto S; Soubeiga AP; Soga A; Iyori M; Yoshida S
    Malar J; 2016 Apr; 15(1):251. PubMed ID: 27129682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice.
    Arama C; Assefaw-Redda Y; Rodriguez A; Fernández C; Corradin G; Kaufmann SH; Reece ST; Troye-Blomberg M
    Vaccine; 2012 Jun; 30(27):4040-5. PubMed ID: 22521849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.
    Kazmin D; Nakaya HI; Lee EK; Johnson MJ; van der Most R; van den Berg RA; Ballou WR; Jongert E; Wille-Reece U; Ockenhouse C; Aderem A; Zak DE; Sadoff J; Hendriks J; Wrammert J; Ahmed R; Pulendran B
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2425-2430. PubMed ID: 28193898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice.
    Deal C; Balazs AB; Espinosa DA; Zavala F; Baltimore D; Ketner G
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12528-32. PubMed ID: 25114213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein.
    Raghunandan R; Mayer BT; Flores-Garcia Y; Gerber MW; Gottardo R; Jhun H; Herrera SM; Perez-Ramos DW; Locke E; King CR; Zavala F
    Malar J; 2020 Mar; 19(1):113. PubMed ID: 32183833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge.
    Romero JF; Ciabattini A; Guillaume P; Frank G; Ruggiero P; Pettini E; Del Giudice G; Medaglini D; Corradin G
    Vaccine; 2009 Feb; 27(8):1266-71. PubMed ID: 19111883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection.
    Yoshida S; Kondoh D; Arai E; Matsuoka H; Seki C; Tanaka T; Okada M; Ishii A
    Virology; 2003 Nov; 316(1):161-70. PubMed ID: 14599800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a sporozoite antigen common to Plasmodium falciparum and Plasmodium berghei.
    Sina BJ; Wright C; Atkinson CT; Ballou R; Aikawa M; Hollingdale M
    Mol Biochem Parasitol; 1995 Feb; 69(2):239-46. PubMed ID: 7770087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
    Nganou-Makamdop K; Ploemen I; Behet M; Van Gemert GJ; Hermsen C; Roestenberg M; Sauerwein RW
    Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.